Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7 (original) (raw)
References
Daley GQ, Baltimore D . Transformation of an interleukin-3 dependent hematopoietic cell line by the chronic myelogenous specific P210 bcr/abl protein Proc Natl Acad Sci USA 1988 85: 9312–9316 ArticleCASPubMedPubMed Central Google Scholar
Kabarowski JH, Allen PB, Wiedemann LM . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells EMBO J 1994 13: 5887–5895 ArticleCASPubMedPubMed Central Google Scholar
Sirard C, Laneuville P, Dick JE . Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism Blood 1994 83: 1575–1585 CASPubMed Google Scholar
Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T . Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway EMBO J 1994 13: 764–773 ArticleCASPubMedPubMed Central Google Scholar
Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B . Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood 1995 86: 726–736 CASPubMed Google Scholar
Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ . Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia J Biol Chem 1994 269: 22925–22928 CASPubMed Google Scholar
McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death Blood 1994 83: 1179–1187 CASPubMed Google Scholar
Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ . Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood 1994 83: 2038–2044 CASPubMed Google Scholar
Albrecht T, Schwab R, Henkes M, Peschel C, Huber C, Aulitzky WE . Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal Br J Haematol 1996 95: 501–507 ArticleCASPubMed Google Scholar
Amos TA, Lewis JL, Grand FH, Gooding RP, Goldman JM, Gordon MY . Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids Br J Haematol 1995 91: 387–393 ArticleCASPubMed Google Scholar
Eaves AC, Eaves CJ . Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML) Exp Hematol 1979 7: (Suppl. 5) 65–75 PubMed Google Scholar
Issaad C, Vainchenker W . Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor Blood 1994 84: 3447–3456 CASPubMed Google Scholar
Druker BJ, Tamura S, Buchdunger E, Ohno S, Bagby GC, Segal GM, Fanning S, Zimmermann J, Lydon NB . Effects of a selective inhibitor of the abl tyrosine kinase on the growth of BCR-ABL positive cells Nature Med 1996 2: 561–566 ArticleCASPubMed Google Scholar
Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG . BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner Oncogene 1998 16: 335–348 ArticleCASPubMed Google Scholar
Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y . Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte–macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival Cancer Res 1991 51: 341–348 CASPubMed Google Scholar
Turhan AG, Eaves CJ, Sutherland HJ, Humphries RK . Retrovirus-mediated transfer of the BCR-ABL (p210) gene to highly purified primitive human hemopoietic cells and the generation of Epo-independent progeny Blood 1991 78: (Suppl. 1) 1341 Google Scholar
Hariharan IK, Adams JM, Cory S . bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia Oncogene Res 1988 3: 387–399 CASPubMed Google Scholar
Hawley RG, Lieu FH, Fong AZ, Hawley TS . Versatile retroviral vectors for potential use in gene therapy Gene Therapy 1994 1: 136–138 CASPubMed Google Scholar
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C . A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Meth 1991 139: 271–279 ArticleCAS Google Scholar
Bowtell DD, Cory S, Johnson GR, Gonda TJ . Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes J Virol 1988 62: 2464–2473 CASPubMedPubMed Central Google Scholar
Artelt P, Grannemann R, Stocking C, Friel J, Bartsch J, Hauser H . The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells Gene 1991 99: 249–254 ArticleCASPubMed Google Scholar
Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N . New understanding of the pathogenesis of CML: a prototype of early neoplasia Leukemia 1997 11: 1404–1428 ArticleCASPubMed Google Scholar
Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst TJ, Griffin JD . Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL J Biol Chem 1994 269: 5016–5021 CASPubMed Google Scholar
Okuda K, Matulonis U, Salgia R, Kanakura Y, Druker B, Griffin JD . Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1 Exp Hematol 1994 22: 1111–1117 CASPubMed Google Scholar
Carlesso N, Frank DA, Griffin JD . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl J Exp Med 1996 183: 811–820 ArticleCASPubMed Google Scholar
Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B . p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells Cell 1997 88: 197–204 ArticleCASPubMed Google Scholar
Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM . Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway Genes Dev 1998 12: 1415–1424 ArticleCASPubMedPubMed Central Google Scholar
Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ . Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells Proc Natl Acad Sci USA 1986 83: 5306–5310 ArticleCASPubMedPubMed Central Google Scholar
Laneuville P, Sun G, Timm M, Vekemans M . Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl Blood 1992 80: 1788–1797 CASPubMed Google Scholar
Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB . Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients Am J Clin Pathol 1996 106: 442–448 ArticleCASPubMed Google Scholar
Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JY, Arlinghaus RB . BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy Blood 1994 83: 3629–3637 CASPubMed Google Scholar
Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M . Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences Leuk Lymphoma 1997 25: 121–133 ArticleCASPubMed Google Scholar
Gaiger A, Henn T, Horth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T . Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression Blood 1995 86: 2371–2378 CASPubMed Google Scholar
Pierce A, Owen-Lynch PJ, Spooncer E, Dexter TM, Whetton AD . p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia Oncogene 1998 17: 667–672 ArticleCASPubMed Google Scholar
Ahmed M, Dusanter-Fourt I, Bernard M, Mayeux P, Hawley RG, Bennardo T, Novault S, Bonnet ML, Gisselbrecht S, Varet B, Turhan AG . BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line Oncogene 1998 16: 489–496 ArticleCASPubMed Google Scholar
Kabarowski JH, Allen PB, Wiedemann LM . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells EMBO J 1994 13: 5887–5895 ArticleCASPubMedPubMed Central Google Scholar
Biernaux C, Loos M, Sels A, Huez G, Stryckmans P . Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals Blood 1995 86: 3118–3122 CASPubMed Google Scholar